70 related articles for article (PubMed ID: 31037767)
1. Identification of key transcription factors in endometrial cancer by systems bioinformatics analysis.
Song Y; Chen QT; He QQ
J Cell Biochem; 2019 Sep; 120(9):15443-15454. PubMed ID: 31037767
[TBL] [Abstract][Full Text] [Related]
2. A multi-omics approach for biomarker discovery in neuroblastoma: a network-based framework.
Hussein R; Abou-Shanab AM; Badr E
NPJ Syst Biol Appl; 2024 May; 10(1):52. PubMed ID: 38760476
[TBL] [Abstract][Full Text] [Related]
3. Identification of core genes in the progression of endometrial cancer and cancer cell-derived exosomes by an integrative analysis.
Shi S; Tan Q; Feng F; Huang H; Liang J; Cao D; Wang Z
Sci Rep; 2020 Jun; 10(1):9862. PubMed ID: 32555395
[TBL] [Abstract][Full Text] [Related]
4. miREC: a database of miRNAs involved in the development of endometrial cancer.
Ulfenborg B; Jurcevic S; Lindlöf A; Klinga-Levan K; Olsson B
BMC Res Notes; 2015 Mar; 8():104. PubMed ID: 25889518
[TBL] [Abstract][Full Text] [Related]
5. Inference of phenotype-relevant transcriptional regulatory networks elucidates cancer type-specific regulatory mechanisms in a pan-cancer study.
Emad A; Sinha S
NPJ Syst Biol Appl; 2021 Feb; 7(1):9. PubMed ID: 33558504
[TBL] [Abstract][Full Text] [Related]
6. A Multi-Omics Approach Revealed Common Dysregulated Pathways in Type One and Type Two Endometrial Cancers.
Capaci V; Monasta L; Aloisio M; Sommella E; Salviati E; Campiglia P; Basilicata MG; Kharrat F; Licastro D; Di Lorenzo G; Romano F; Ricci G; Ura B
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003247
[TBL] [Abstract][Full Text] [Related]
7. In Silico discovery of transcription factors as potential diagnostic biomarkers of ovarian cancer.
Kaur M; MacPherson CR; Schmeier S; Narasimhan K; Choolani M; Bajic VB
BMC Syst Biol; 2011 Sep; 5():144. PubMed ID: 21923952
[TBL] [Abstract][Full Text] [Related]
8. Discovery of the potential biomarkers for early diagnosis of endometrial cancer via integrating metabolomics and transcriptomics.
Fu Y; Wang C; Wu Z; Zhang X; Liu Y; Wang X; Liu F; Chen Y; Zhang Y; Zhao H; Wang Q
Comput Biol Med; 2024 May; 173():108327. PubMed ID: 38552279
[TBL] [Abstract][Full Text] [Related]
9. Identification of Biomarkers Related to the Efficacy of Radiotherapy in Pancreatic Cancer.
Caxali GH; Brugnerotto L; Aal MCE; Castro CFB; Delella FK
Cancer Genomics Proteomics; 2023; 20(5):487-499. PubMed ID: 37643780
[TBL] [Abstract][Full Text] [Related]
10. Meta-dimensional data integration identifies critical pathways for susceptibility, tumorigenesis and progression of endometrial cancer.
Wei R; De Vivo I; Huang S; Zhu X; Risch H; Moore JH; Yu H; Garmire LX
Oncotarget; 2016 Aug; 7(34):55249-55263. PubMed ID: 27409342
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers discovery for endometrial cancer: A graph convolutional sample network method.
Wu E; Fan X; Tang T; Li J; Wang J; Liu X; Zungar Z; Ren J; Wu C; Shen B
Comput Biol Med; 2022 Nov; 150():106200. PubMed ID: 37859290
[TBL] [Abstract][Full Text] [Related]
12. Circuits of cancer drivers revealed by convergent misregulation of transcription factor targets across tumor types.
Gonzalez-Perez A
Genome Med; 2016 Jan; 8(1):6. PubMed ID: 26792175
[TBL] [Abstract][Full Text] [Related]
13. Etiological relationship between lipid metabolism and endometrial carcinoma.
Li W; Xu Y; Zeng X; Tan J; Wang Y; Wu H; Li M; Yi C
Lipids Health Dis; 2023 Aug; 22(1):116. PubMed ID: 37537560
[TBL] [Abstract][Full Text] [Related]
14. Identification and subsequent validation of transcriptomic signature associated with metabolic status in endometrial cancer.
Sidorkiewicz I; Jóźwik M; Buczyńska A; Erol A; Jóźwik M; Moniuszko M; Jarząbek K; Niemira M; Krętowski A
Sci Rep; 2023 Aug; 13(1):13763. PubMed ID: 37612452
[TBL] [Abstract][Full Text] [Related]
15. Identification of Potentially Novel Molecular Targets of Endometrial Cancer Using a Non-Biased Proteomic Approach.
Taylor AH; Konje JC; Ayakannu T
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760635
[TBL] [Abstract][Full Text] [Related]
16. Novel Molecular Targets in Endometrial Cancer: Mechanisms and Perspectives for Therapy.
Soberanis Pina P; Lheureux S
Biologics; 2024; 18():79-93. PubMed ID: 38529411
[TBL] [Abstract][Full Text] [Related]
17. Comparative transcriptome analysis between patient and endometrial cancer cell lines to determine common signaling pathways and markers linked to cancer progression.
Cho-Clark MJ; Sukumar G; Vidal NM; Raiciulescu S; Oyola MG; Olsen C; Mariño-Ramírez L; Dalgard CL; Wu TJ
Oncotarget; 2021 Dec; 12(26):2500-2513. PubMed ID: 34966482
[TBL] [Abstract][Full Text] [Related]
18. Identification of Novel Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma using Bioinformatics Analysis.
Ding Y; Li M; Tayier T; Chen L; Feng S
Comb Chem High Throughput Screen; 2021; 24(9):1351-1363. PubMed ID: 33109035
[TBL] [Abstract][Full Text] [Related]
19. Eleven genes associated with progression and prognosis of endometrial cancer (EC) identified by comprehensive bioinformatics analysis.
Liu J; Zhou S; Li S; Jiang Y; Wan Y; Ma X; Cheng W
Cancer Cell Int; 2019; 19():136. PubMed ID: 31139013
[TBL] [Abstract][Full Text] [Related]
20. Identification of biomarkers correlated with diagnosis and prognosis of endometrial cancer using bioinformatics analysis.
Zhao H; Jiang A; Yu M; Bao H
J Cell Biochem; 2020 Dec; 121(12):4908-4921. PubMed ID: 32692884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
